Recent Headlines
EU Novel Foods Approved for Vitamin K2 Ingredient
Chrysalis Health & Beauty have announced the availability of Kappa K2Vital Vitamin K2 MK7 raw material for the UK and export markets following the successful EU Novel foods approval for this essential nutrient. - March 30, 2012 - Chrysalis Health & Beauty Business Solutions Limited
Foamix’s Minocycline Foam – 100% Effective in Impetigo Phase II Clinical Trial with No Side Effects. 80% Improved Significantly After 3 Days of Treatment.
Targets a $1 billion a year market. Foamix, a clinical stage specialty pharmaceutical company, announced today the successful completion of the Phase II clinical trial of Minocycline foam in Impetigo patients. Minocycline Foam has shown to be highly effective against bacteria, including some multi-drug resistant strains (such as MRSA). - March 20, 2012 - Foamix Ltd
New Book Release
CGMP University inc of San Jose announced the release of two books: 1. How to design a Pharmaceutical Quality system. 2. Principles of design controls for medical device. - March 16, 2012 - cGMP UNIVERSITY INC.
Foamix Granted Comprehensive US Patent for PerFoam® – Ideal Foam Treatment for Head Lice and Scabies
Foamix Ltd., a clinical-stage specialty pharmaceutical company, that is developing proprietary dermatological and gynecologic topical foam products, today announced that the company has been granted a new patent from United States Patent Office. - March 15, 2012 - Foamix Ltd
Foamix Obtains US Patent for Iodine Foam – Innovative Treatment for Heat Burns and Warfare Materials, as Well as Fungal and Bacterial Infection
Foamix Ltd., a clinical-stage specialty pharmaceutical company, that is developing proprietary dermatological and gynecologic topical foam products, today announced that the company has been granted a new patent from United States Patent Office. - March 13, 2012 - Foamix Ltd
New Foamix US Patent: "Foamable Compositions, Kits and Methods for Hyperhidrosis" - First in Class Foam for Excessive Sweating
Foamix Ltd., a clinical-stage specialty pharmaceutical company, that is developing proprietary dermatological and gynecologic topical foam products, today announced that the company has been granted a new patent from United States Patent Office. - March 13, 2012 - Foamix Ltd
Ameridose Continues Outstanding Sustainability Performance
Ameridose, LLC, nationwide provider of sterile admixing services to hospital pharmacies, is pleased to present outstanding 2011 sustainability results. Recycled materials generated from Ameridose facilities totaled 1.9 million lbs. Corrugated cardboard dominated with over 600,000 lbs, empty glass... - March 06, 2012 - Ameridose, LLC
CPC Scientific Announces Its Peptide Facility Passes 2nd Successful FDA Inspection
CPC Scientific is pleased to announce that its 50,000 sf cGMP peptide facility has successfully passed a second US Food and Drug Administration (FDA) inspection. It involved the investigator inspecting CPC Scientific’s peptide production facilities, manufacturing processes, laboratory control... - February 27, 2012 - CPC Scientific
Chrysalis Health & Beauty to Distribute Albion Minerals Range of Mineral Ingredients
Chrysalis Health & Beauty announced as the new UK sales agents for the renowned range of Albion Mineral products. - February 13, 2012 - Chrysalis Health & Beauty Business Solutions Limited
Foamix Obtains India Patent for Its Emollient Foam Platform – The Ideal Vehicle for Dermatological Drugs
Foamix Ltd., a clinical-stage specialty pharmaceutical company, that is developing proprietary dermatological and gynecologic topical foam products, today announced that the company has been granted a patent from Indian Patent Office # IN 249626, entitled “Foam Carrier Containing Amphiphilic Copolymeric Gelling Agent.” - February 10, 2012 - Foamix Ltd
Sunsafe Rx®: the Pill That Protects Your Skin from the Sun
Napa Valley Bioscience announces the launch of Sunsafe Rx®: a natural, premium nutritional supplement that helps your skin naturally defend against sun damage. A revolutionary new product, Sunsafe Rx® is designed to defend against the aging effects of both UVA and UVB rays without affecting your body's natural production of Vitamin D. - January 27, 2012 - Napa Valley Bioscience
Autoscribe Launches US Operation
The formation of Autoscribe Informatics Inc., a wholly owned subsidiary of Autoscribe Ltd, has been announced. Based in Falmouth, MA, USA, it gives Autoscribe, the developers of Matrix software products, a much stronger presence in the US and Canadian markets. Zumatrix Inc. operated as... - January 12, 2012 - Autoscribe Informatics
AdvaCare Veterinary Product Line Growing Into New Markets
AdvaCare is a leader in supplying Veterinary products to its importers and distributors in markets and regions throughout Africa, the Middle East, Asia, and South America. AdvaCare's facilities are GMP approved and have the necessary documentation for registration in existing and new markets. - December 29, 2011 - AdvaCare Pharmaceutical
AdvaCare Looking for Qualified Importers & Distributors in Key Markets
As AdvaCare is expanding into new markets, as well as growing its product range to meet demand in these new markets, AdvaCare is interested in suitable importers and distributors joining the AdvaCare team. AdvaCare is interested in qualified distributors, preferably with product registration... - December 29, 2011 - AdvaCare Pharmaceutical
AdvaCare Expanding Into East European Market
AdvaCare, already having a strong presence in countries throughout Africa, Asia, the Middle East and South America, is now introducing its Pharmaceutical, Antimalarial, Oncology, Veterinary and Medical Supplies products to the East European region. AdvaCare is an American company with production in... - December 28, 2011 - AdvaCare Pharmaceutical
Ameridose Participates in Holiday Food Drive
Ameridose, LLC, nationwide provider of sterile admixing services to hospital pharmacies, is pleased to give back to the community of Westborough, MA by conducting a holiday food drive to benefit the Westborough Food Pantry. The food pantry currently distributes about 2000 lbs of food per week to... - December 20, 2011 - Ameridose, LLC
Chrysalis Offer Red Yeast Rice a Proven Natural Solution for Cholesterol Reduction
Chrysalis Health & Beauty Limited have announced the availability of new range of Red Yeast Rice products providing effective LDL cholesterol reduction. - December 13, 2011 - Chrysalis Health & Beauty Business Solutions Limited
Chrysalis Health & Beauty Launch New Food Supplement Beads for Private Label
Chrysalis Health & Beauty Limited have announced the availability of new range of food supplement beads with modified active ingredient release profiles for private label. - December 07, 2011 - Chrysalis Health & Beauty Business Solutions Limited
Chrysalis Offers EFSA Approved Weight Management Products for Private Label
Chrysalis Health & Beauty Limited have announced the availability of new weight Management products for the EU market. The new slimming products based on glucomannan are formulated to meet the "positive opinion" claims provided by EFSA (European Food Safety Authority) and are being made available by Chrysalis for customer private label. - December 06, 2011 - Chrysalis Health & Beauty Business Solutions Limited
Ameridose Presents Second and Third Quarter Sustainability Results
Ameridose, LLC, nationwide provider of sterile admixing services to hospital pharmacies, is proud to announce strong sustainability results for the second and third quarters of 2011. Recycled materials generated from Ameridose facilities were close to half a million pounds for each quarter, with a... - October 11, 2011 - Ameridose, LLC
FyMed Reinforces Its Drug Development Pipeline with Novel Strategies in Personalized Medicine
FyMed, Inc., a biopharmaceutical company utilizing proprietary methodologies in evidence-based medicine for drug discoveries, recently announced plans for the strategic and operational reinforcements of their drug development pipeline through innovative approaches in personalized medicine. - October 06, 2011 - FyMed Inc
Launch of Biotechnology Portal cellexis.com – Marketing of Innovative Cell Culture Technology
atech system solutions Ltd. (“atech”) has launched the online service www.cellexis.com for marketing and distribution of innovative products and services in the field of cell culture technology. The online service www.cellexis.com is the portal for distribution of bioreactor systems that are marketed under the name “cellexis one” and services like the delivery of manufacturing processes for cell culture products according to international standards. - September 22, 2011 - atech system solutions Ltd.
atech system solutions Develops New Bioreactor Platform for Cell Culture-Based Manufacturing
The atech system solutions Ltd. presents a new generation of bioreactor systems for cell culture-based manufacturing of biopharmaceutical compounds. The new development comprises a platform technology with high performance, safety as well as environmental compatibility and simplification of cell culture-based manufacturing methods. The system platform will be marketed under the brand name “cellexis one.” - September 17, 2011 - atech system solutions Ltd.
Ameridose to Sponsor Health Connect Partners 2011 Fall Hospital Pharmacy Conference
Ameridose, LLC, nationwide provider of sterile admixing services to hospital pharmacies, is pleased to announce its participation as a sponsor of the 2011 Health Connect Partners Fall Hospital Pharmacy Conference. The conference will take place from September 26-28, 2011 at the Arizona Biltmore in... - September 07, 2011 - Ameridose, LLC
Introducing an Optimized Process Management Concept from Drug Development to Drug Manufacturability: Advaceutics®
Reducing risk, defining time lines and increasing cost efficiency on a new drug’s way to commercial scale manufacturing. - August 26, 2011 - ProJect Pharmaceutics GmbH
Survey Reveals: 77% of Dermatologists Will Prescribe Topical Minocycline. Foamix’s First-in-Class Minocycline Foam - Now in Phase II
Most Dermatologists are concerned with Oral Minocycline side effects and will prefer prescribing their patients Topical Minocycline for Rosacea, Acne, Skin Infections and Chronic Wounds. - August 02, 2011 - Foamix Ltd
Ameridose Vice President of Regulatory Affairs and Compliance Presents at LSHP Annual Meeting
Ameridose, LLC, a leading nationwide provider of sterile admixing services to hospital pharmacies, is honored that Ameridose Vice President of Regulatory Affairs and Compliance, Sophia Pasedis, PharmD, was invited to speak at the 2011 Louisiana Society of Health-System Pharmacists (LSHP) Annual... - July 26, 2011 - Ameridose, LLC
Ameridose Supports Annual Meeting for the Louisiana Society of Health-System Pharmacists
Ameridose, LLC, a leading nationwide provider of sterile admixing services to hospital pharmacies, is pleased to have contributed to the 2011 Louisiana Society of Health-System Pharmacists (LSHP) Annual Meeting as both an Educational Sponsor and an Event Sponsor. The annual meeting took place at... - July 19, 2011 - Ameridose, LLC
Ameridose Named Supplier of Choice for Texas Purchasing Coalition
Ameridose, LLC, nationwide provider of sterile admixing services to hospital pharmacies, has been selected as supplier of choice for Texas Purchasing Coalition (TPC) hospitals. The TPC Group currently includes 10 integrated delivery network healthcare systems with 27 facilities, together generating... - June 16, 2011 - Ameridose, LLC
Synvir's Ultrafast Nozzle Speeds Past T-Junction Chips
A new MEMs nozzle produces 100,000 microdroplets per second. - May 31, 2011 - Synvir, Inc.
Arkin and Foamix to Develop an Innovative Acne Foam
Arkin Holdings and Foamix today announced that they have established a collaboration to develop and commercialize an innovative topical foam to treat patients with acne vulgaris and related disorders. - May 27, 2011 - Foamix Ltd
Ameridose Reveals Strong First Quarter Sustainability Results
Ameridose, LLC, nationwide provider of sterile admixing services to hospital pharmacies, is pleased to share impressive sustainability results for the first quarter of 2011. The combined total of recycled materials generated from Ameridose facilities in the first quarter approached half a million... - May 24, 2011 - Ameridose, LLC
Ameridose Demonstrates Commitment to Customer Care Excellence
Ameridose, LLC, a leading nationwide provider of sterile admixing services to hospital pharmacies, demonstrates its unrelenting commitment to customer care excellence through the appointment of Mr. Todd DeAngelis to serve as Vice President of Innovation and Customer Experience. He is charged with... - April 23, 2011 - Ameridose, LLC
ChiroSolve Inc. Launches New Website
ChiroSolve Inc. is excited to announce the launch of its new website - February 26, 2011 - ChiroSolve, Inc.
Ameridose Announces Outstanding 2010 Sustainability Results
Ameridose, LLC, nationwide provider of sterile admixing services to hospital pharmacies, is pleased to announce the impressive results of its 2010 sustainability program. Three Ameridose facilities had combined recycling that totaled over 1.5 million lbs. Recycled materials included day-to-day... - February 22, 2011 - Ameridose, LLC
SynTegra Solutions Announce Expansion of Audit Services
SynTegra Solutions has announced an expansion of their services to include audits of reverse distributors. Validating return transactions to insure compliance with the manufacturer’s return policy is paramount to closing profit leaks. “With returns running at 1-2% of gross sales, many... - February 10, 2011 - SynTegra Solutions, Inc.
ChiroSolve, Inc. Launches New Method Development Kits
ChiroSolve announces the introduction of two new product packages, EnantioPrep and ScalePrep. - February 06, 2011 - ChiroSolve, Inc.
Local Business Teams Up with Expert Physicians to Help Michigan Families Affected by Autism
On February 12, 2011-- Michigan-based Health Dimensions Compounding Pharmacy is joining forces with five local experts on biomedical autism treatments for a one day only event that aims to educate those affected by autism on bio-medical options. - January 26, 2011 - Health Dimensions Compounding Pharmacy
Foamix Announces Phase II Clinical Trial of Topical Minocycline Foam for Rosacea
The first-in-class topical Minocycline product, protected by 4 patent applications, is directed for the treatment of Rosacea, Acne, Skin Infections and Chronic Wounds - January 20, 2011 - Foamix Ltd
Ameridose Opens New State-of-the-Art Sterile Admixing Facility
Ameridose, LLC, nationwide provider of sterile admixing services to hospital pharmacies, is pleased to announce the opening of its third and newest manufacturing facility. Located in Westborough, MA, the new 70,000 sq. ft. facility has been constructed using the finest building materials and contains state-of-the-art clean room equipment. - January 19, 2011 - Ameridose, LLC
Chrysalis Health & Beauty Announce Discounted Range of Food Supplements for Trade Private Label Clients
Chrysalis Health & Beauty Limited are offering a discounted range of quality food supplements to UK & overseas trade clients from January 2011. The low cost food supplements include single and combination vitamin, mineral and natural extracts in tablet, hard capsule and soft capsule formats. Products are offered in both bulk and packed “retail ready” supply from European manufacturing facilities. - January 05, 2011 - Chrysalis Health & Beauty Business Solutions Limited
Nutricap Labs President and Founder Featured in Today’s CEO Executive Suite Column of Newsday
Leader of New York-based vitamin and supplement manufacturing company was featured in today’s CEO Executive Suite column of Newsday to discuss his contributions to various local and national charities and how he grew his business into one of America’s fastest-growing companies despite a global recession. - December 20, 2010 - Nutricap Labs
St Johns Wort Licensed Herbal Medicine Approval
Chrysalis Health & Beauty Limited have announced the availability of a licensed St John’s Wort tablet for private labeling in the UK and overseas. A traditional herbal medicinal product used to relieve the symptoms of slightly low mood and mild anxiety based on traditional use only. - December 03, 2010 - Chrysalis Health & Beauty Business Solutions Limited
Spotaway™- a Licensed Cream for the Treatment of Acne, Spots & Pimples
Chrysalis Health & Beauty Limited have announced the availability of Spotaway™ a licensed OTC medicine for the treatment of Acne, Spots and Pimples for private labeling in the UK and overseas. - December 02, 2010 - Chrysalis Health & Beauty Business Solutions Limited
Echinacea for Colds & Flu- Herbal Medicine License Approval
Chrysalis Health & Beauty Limited have announced the availability of a licensed Echinacea tablet for private labeling in the UK and overseas. A traditional herbal medicinal product used to treat the symptoms of the common cold, influenza and minor upper respiratory tract infections based on traditional use only. - December 01, 2010 - Chrysalis Health & Beauty Business Solutions Limited
Relivergen™- a New Natural Formula to Support and Protect Liver Health
Relivergen™ a new clinically proven liver health formula has been announced by Chrysalis Health & Beauty Limited. The marketing of Relivergen™ is a collaboration between the technology holder Phynova Group Limited and Chrysalis Health & Beauty UK Limited who are seeking distributors for Relivergen™ globally. - November 30, 2010 - Chrysalis Health & Beauty Business Solutions Limited
Wholesale Vitamin and Food Supplement Supply Expansion
Chrysalis Health & Beauty Limited have announced an expansion to their wholesale vitamin and food supplement business for UK and export markets for 2011. Previously a provider of “bulk only” products, Chrysalis will now offer full service packing for private label supply of a full range of vitamin and food supplements in tablet, capsule, powder and liquid formats. - November 30, 2010 - Chrysalis Health & Beauty Business Solutions Limited
FatigFix™- a New Adaptogenic Ingredient for the Relief of Fatigue and Improvement of Sleep Quality
Chrysalis Health & Beauty Business Solutions Limited have announced the launch of FatigFix™, a new clinically proven formula to help reduce symptoms of fatigue and promote improvements in sleep quality. The marketing of Fatigfix™ is a collaboration between the technology holder Phynova Group Limited and Chrysalis Health & Beauty who jointly seek distributors for Fatigfix™ globally. - November 29, 2010 - Chrysalis Health & Beauty Business Solutions Limited
Foamix Receives US Patent for Oleaginous Foam
Oleaginous Foams – Ideal Vehicles for Lipophilic and Water-Sensitive Drugs, such as Vitamin D, Retinoids and Lipophilic Antibiotics. - November 06, 2010 - Foamix Ltd
Foamix and BioMAS to Develop Novel Therapy for Genital Warts
The New Drug Will Target One of the Most Common Sexually Transmitted Disease, Afflicting More Than 20 Million Americans. - November 03, 2010 - Foamix Ltd